Etiology and pathogenesis of achalasia: The current understanding

American Journal of Gastroenterology

Volumn 100, Issue 6, 2005, Pages 1404-1414

  Park, Woosuk ^a   Vaezi, Michael F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; AUTOANTIBODY; CARBON 14; CHOLECYSTOKININ OCTAPEPTIDE; CITRULLINE; HLA ANTIGEN CLASS 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; VASOACTIVE INTESTINAL POLYPEPTIDE; VIRUS DNA;

ANIMAL MODEL; AUTOIMMUNE DISEASE; CELL LOSS; COMPLEMENT FIXATION TEST; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA HYBRIDIZATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS ACHALASIA; ESOPHAGUS MYOTOMY; ESOPHAGUS RESECTION; FAMILIAL DISEASE; GENETIC SUSCEPTIBILITY; HEMAGGLUTINATION INHIBITION TEST; HLA TYPING; HUMAN; IDIOPATHIC DISEASE; INFECTION; INFLAMMATORY DISEASE; INFLAMMATORY INFILTRATE; INNERVATION; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MEASLES VIRUS; MYENTERIC PLEXUS; NERVE CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VAGUS NERVE; VARICELLA ZOSTER VIRUS;

ESOPHAGEAL ACHALASIA; ESOPHAGUS; HUMANS; PERISTALSIS; RISK FACTORS;

EID: 21344438164     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.41775.x     Document Type: Review

References (111)

1. Birgisson S, Richter JE. Achalasia: What's new in diagnosis and treatment? Dig Dis 1997;15(suppl 1):1-27 (Review).
2. Paterson WG. Etiology and pathogenesis of achalasia. Gastrointest Endosc Clin N Am 2001 Apr; 11:249-66 (vi. Review).
3. Bieger D, Hopkins DA. Viscerotopic representation of the upper alimentary tract in the medulla oblongata in the rat: The nucleus ambiguous. J Comp Neurol 1987;262:546-62.
4. Toyama T, Yokoyama I, Nishi K. Effects of hexamethonium and other ganglionic blocking agents on electrical activity of the esophagus induced by vagal stimulation in the dog. Eur J Pharmacol 1975;31:63-71.
5. Collman PI, Tremblay L, Diamant NE. The central vagal efferent supply to the esophagus and lower esophageal sphincter of the cat. Gastroenterology 1993;104:1430-8.
6. Goyal RK, Rattan S. Nature of the vagal inhibitory innervation to the lower esophageal sphincter. J Clin Invest 1974-1975; 55:1119-26.
7. Goyal RK, Rattan S. VIP as a possible neurotransmitter of non-cholinergic non-adrenergic inhibitory neurons. Nature 1980;288:378-9.
8. Yamato S, Spechler SJ, Goyal RK. Role of nitric oxide in esophageal peristalsis in the opossum. Gastroenterology 1992;103:197-204.
9. Crist J, Gidda JS, Goyal RK. Intramural mechanism of esophageal peristalsis: Roles of cholinergic and noncholinergic nerves. Proc Natl Acad Sci USA 1984;81:3595-9.
10. Aggestrup S, Uddman R, Jensen SL, et al. Regulatory peptides in the lower esophageal sphincter of man. Regul Pept 1985;10:167-78.
11. Mearin F, Mourelle M, Guarner F, et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest 1993;23:724-8.
12. Kimura K. The nature of idiopathic esophagus dilatation. Jpn J Gastroenterol 1929;1:199.
13. Cassella RR, Brown AL Jr, Sayre GP, et al. Achalasia of the esophagus: Pathologic and etiologic considerations. Ann Surg 1964;160:474-87.
14. Higgs B, Kerr FW, Ellis FH Jr. The experimental production of esophageal achalasia by electrolytic lesions in the medulla. J Thorac Cardiovasc Surg 1965;50:613-25.
15. Cassella RR, Ellis FH Jr, Brown AL Jr. Fine structure changes in achalasia of the esophagus: I. Vagus nerves. Am J Pathol 1965;46:279-88.
16. Duntemann TJ, Dresner DM. Achalasia-like syndrome presenting after highly selective vagotomy. Dig Dis Sci 1995;40:2081-3.
17. Atkinson M, Ogilvie AL, Robertson CS, et al. Vagal function in achalasia of the cardia. Q J Med 1987;63:297-303.
18. Eckardt VF, Krause J, Bolle D. Gastrointestinal transit and gastric acid secretion in patients with achalasia. Dig Dis Sci 1989;34:665-71.
19. Khajanchee YS, VanAndel R, Jobe BA, et al. Electrical stimulation of the vagus nerve restores motility in an animal model of achalasia. J Gastrointest Surg 2003;7:843-9.
20. Holloway RH, Dodds WJ, Helm JF, et al. Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterololgy 1986;90:924-929.
21. Greaves RR, Mulcahy HE, Patchett SE, et al. Early experience with intrasphincteric botulinum toxin in the treatment of achalasia. Aliment Pharmacol Ther 1999;13:1221-5.
22. Dodds WJ, Dent J, Hogan WJ, et al. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterololgy 1981;80:327-33.
23. Tøttrup A, Forman A, Funch-Jensen P, et al. Effects of postganglionic nerve stimulation in oesophageal achalasia: An in vitro study. Gut 1990;31:17-20.
24. Paterson WG. Esophageal and lower esophageal sphincter response to balloon distention in patients with achalasia. Dig Dis Sci 1997;42:106-112.
25. Biancani P, Walsh JH, Behar J. Vasoactive intestinal polypeptide. A neurotransmitter for lower esophageal sphincter relaxation. J Clin Invest 1984;73:963-7.
26. Rattan S. The non-adrenergic non-cholinergic innervation of the esophagus and the lower esophageal sphincter. Arch Int Pharmacodyn Ther 1986;280(suppl 2):62-83.
27. Rattan S, Moummi C. Influence of stimulators and inhibitors of cyclic nucleotides on lower esophageal sphincter. J Pharmacol Exp Ther 1989;248:703-709.
28. Rattan S, Said SI, Goyal RK. Effect of vasoactive intestinal polypeptide (VIP) on the lower esopohageal sphincter pressure (LESP). Proc Soc Exp Med 1977;155: 40-3.
29. Guelrud M, Rossiter A, Souney PF, et al. The effect of vasoactive intestinal polypeptide on the lower esophageal sphincter in achalasia. Gastroenterology 1992;103:377-82.
30. Uddman R, Alumets J, Edvinsson L, et al. Peptidergic (VIP) innervation of the esophagus. Gastroenterology 1978;75:5-8.
31. Wattchow DA, Furness JB, Costa M, et al. Distributions of neuropeptides in the human esophagus. Gastroenterology 1987;93:1363-71.
32. Aggestrup S, Uddman R, Sundler F, et al. Lack of vasoactive intestinal peptide nerves in esophageal achalasia. Gastroenterology 1983;84:924-927.
33. Gridelli B, Buffa R, Salvini P. Lack of VIP-immunoreactive nerves in oesophageal achalasia. Ital J Gastroenterol 1982;14:211-13.
34. Sigala S, Missale G, Missale C, et al. Different neurotransmitter systems are involved in the development of esophageal achalasia. Life Sci 1995;56:1311-20.
35. Wattchow DA, Costa M. Distribution of peptide-containing nerve fibers in achalasia of the oesophagus. J Gastroenterol Hepatol 1996;11:478-85.
36. Tøttrup A, Svane D, Forman A. Nitric oxide mediating NANC inhibition in opossum lower esophageal sphincter. Am J Physiol 1991;260:G385-9.
37. Murray J, Du C, Ledlow A, et al. Nitric oxide: Mediator of nonadrenergic noncholinergic responses of opossum esopohageal muscle. Am J Physiol 1991;261:G401-6.
38. Du C, Murray J, Bates JN, et al. Nitric oxide: Mediator of nonadrenergic noncholinergic hyperpolarization of opossum esophageal muscle. Am J Physiol 1991;261:G1012-16.
39. Conklin JL, Du C, Murray J, et al. Characterization and mediation of inhibitory junction potentials from the opossum lower esophageal sphincter. Gastroenterology 1993;104:1439-44.
40. Fang S, Christensen J. Distribution of NADPH diaphorase in intramural plexuses of cat and opossum esophagus. J Auton Nerv Syst 1993;46:123-33.
41. Murray J, Bates JN, Conklin JL. Nerve-mediated nitric oxide production by the opossum lower esophageal sphincter. Dig Dis Sci 1994;39:1872-6.
42. Murray JA, Clark ED. Characterization of nitric oxide synthase in the opossum esophagus. Gastroenterology 1994;106:1444-50.
43. Gaumnitz EA, Bass P, Osinski MA, et al. Electrophysiological and pharmacological responses of chronically denervated lower esophageal sphincter of the opossum. Gastroenterology 1995;109:789-99.
44. Kim CD, Goyal RK, Mashimo H. Neuronal NOS provides nitergic inhibitory neurotransmitter in mouse lower esophageal sphincter. Am J Physiol 1999;277:6280-4.
45. Paterson WG, Anderson MA, Anand N. Pharmacological characterization of lower esophageal sphincter relaxation induced by swallowing, vagal efferent nerve stimulation, and esophageal distention. Can J Physiol Pharmacol 1992;70:1011-5.
46. V mutant mice. Gastroenterology 2001;121:34-42.
47. De Giorgio R, Di Simone MP, Stanghellini V, et al. Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am J Gastroenterol 1999;94:2357-62.
48. Murray JA, Ledlow A, Launspach J, et al. The effects of recombinant human hemoglobin on esophageal motor functions in humans. Gastroenterology 1995;109:1241-8.
49. Singaram C, Sengupta A, Sweet MA, et al. Nitrinergic and peptidergic innervation of the human oesophagus. Gut 1994;35:1690-6.
50. Lendrum FC. Anatomic features of the cardiac orifice of the stomach with special reference to cardiospasm. Arch Intern Med 1937;59:474.
51. Cassella RR, Brown AL Jr, Sayre GP, et al. Achalasia of the esophagus: Pathologic and etiologic considerations. Ann Surg 1964;160:474-7.
52. Qualman SJ, Haupt HM, Yang P, et al. Esophageal lewy bodies associated with ganglion cell loss in achalasia. Gastroenterology 1984;87:848-56.
53. Misiewicz JJ, Waller SL, Anthony PP, et al. Achalasia of the cardia: Pharmacology and histopathology of isolated cardiac sphincteric muscle from patients with and without achalasia. Q J Med 1969;38:17-30.
54. Csendes A, Smok G, Braghetto I, et al. Gastroesophageal sphincter pressure and histological changes in distal esophagus in patients with achalasia of the esophagus. Dig Dis Sci 1985;30:941-5.
55. Csendes A, Smok G, Braghetto I, et al. Histological studies of Auerbach's plexuses of the oesophagus, stomach, jejunum, and colon in patients with achalasia of the oesophagus: Correlation with gastric acid secretion, presence of parietal cells and gastric emptying of solids. Gut 1992;33:150-4.
56. Goldblum JR, Whyte RI, Orringer MB, et al. Achalasia: A morphologic study of 42 resected specimens. Am J Surg Pathol 1994;18:327-37.
57. Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996;111:648-54.
58. Raymond L, Lach B, Shamji FM. Inflammatory aetiology of primary oesophageal achalasia: An immunohistochemical and ultrastructural study of Auerbach's plexus. Histopathology 1999;35:445-53.
59. Clark SB, Rice TW, Tubbs RR, et al. The nature of the myenteric infiltrate in achalasia: An immunohistochemical analysis. Am J Surg Pathol 2000;24:1153-8.
60. Lehman MB, Clark SB, Ormsby AH, et al. Squamous mucosal alterations in esophagectomy specimens from patients with end-stage achalasia. Am J Surg Pathol 2001;25:1413-18.
61. Cassella RR, Brown AL Jr, Sayre GP, et al. Achalasia of the esophagus: Pathologic and etiologic considerations. Ann Surg 1964;160:474-87.
62. Parrilla P, Aguayo JL, Martinez de Haro L, et al. Reversible achalasia-like motor pattern of esophageal body secondary to postoperative stricture of gastroesophageal junction. Dig Dis Sci 1992;37:1781-4.
63. Parrilla P, Martinez LF, Ortiz A, et al. Factors involved in the return of peristalsis in patients with achalasia of the cardia after Heller's myotomy. Am J Gastroenterol 1995;90:713-17.
64. Papo M, Mearin F, Castro A, et al. Chest pain and reappearance of esophageal peristalsis in treated achalasia. Scand J Gastroenterol 1997;32:1190-4.
65. Little AG, Correnti FS, Calleja IJ, et al. Effect of incomplete obstruction on feline esophageal function with a clinical correlation. Surgery 1986;100:430-6.
66. Schneider JH, Peters JH, Kirkman E, et al. Are the motility abnormalities of achalasia reversible? An experimental outflow obstruction in the feline model. Surgery 1999;125:498-503.
67. Singaram C, Sweet MA, Gaumnitz EA, et al. Evaluation of early events in the creation of a myenteric opossum model of achalasia. Neurogastroenterol Motil 1996;8:351-61.
68. Sonnenberg A, Massey BT, McCarty DJ, et al. Epidemiology of hospitalization for achalasia in the United States. Dig Dis Sci 1993;38:233-44.
69. Johnston BT, Colcher A, Li Q, et al. Repetitive proximal esophageal contractions: A new manometric finding and a possible further link between Parkinson's disease and achalasia. Dysphagia 2001;16:186-189.
70. Murphy MS, Gardner-Medwin D, Eastham EJ. Achalasia of the cardia associated with hereditary cerebellar ataxia. Am J Gastroenterol 1989;84:1329-1330.
71. Foster PN, Stewart M, Lowe JS, et al. Achalasia like disorder of the oesophagus in von Recklinghausen's neurofibromatosis. Gut 1987;28:1522-6.
72. Frieling T, Berges W, Borchard F, et al. Family occurrence of achalasia and diffuse spasm of the oesophagus. Gut 1988;29:1595-602.
73. Stein DT, Knauer CM. Achalasia in monozygotic twins. Dig Dis Sci 1982;27:636-40.
74. Annese V, Napolitano G, Minervini MM, et al. Family occurrence of achalasia. J Clin Gastroenterol 1995;20:329-30.
75. Bosher LP, Shaw A. Achalasia in siblings. Clinical and genetic aspects. Am J Dis Child 1981;135:709-10.
76. Kaar TK, Waldron R, Ashraf MS, et al. Familial infantile oesophageal achalasia. Arch Dis Child 1991;66:1353-4.
77. London FA, Raab DE, Fuller J. Achalasia in three siblings: A rare occurrence. Mayo Clin Proc 1977;52:97-100.
78. Mayberry JF, Atkinson M. A study of swallowing difficulties in first degree relatives of patients with achalasia. Thorax 1985;40:391-3.
79. Zarate N, Mearin F, Gil-Vernet JM, et al. Achalasia and Down's syndrome: Coincidental association or something else? Am J Gastroenterol 1999;94:1674-7.
80. Allgrove J, Clayden GS, Grant DB, et al. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 1978;1:1284-6.
81. Weber A, Wienker TF, Jung M, et al. Linkage of the gene for the triple A syndrome to chromosome 12q13 near the type II keratin gene cluster. Hum Mol Genet 1996;5:2061-6.
82. Houlden H, Smith S, De Carvalho M, et al. Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain 2002;125(Pt 12):2681-90.
83. Firouzi M, Keshavarzian A. Guillain-Barre syndrome and achalasia: Two manifestations of a viral disease or coincidental association? Am J Gastroenterol 1994;89:1585-7.
84. Dantas RO, Meneghelli UG. Achalasia occurring years after acute poliomyelitis. Arq Gastroenterol 1993;30:58-61.
85. Benini L, Sembenini C, Bulighin GM, et al. Achalasia. A possible late cause of postpolio dysphagia. Dig Dis Sci 1996;41:516-518.
86. Castex F, Guillemot F, Talbodec N, et al. Association of an attack of varicella and an achalasia. Am J Gastroenterol 1995;90:1188-9.
87. Giger M, Uehlinger M, Pedio G, et al. Diagnosis and occurrence of viral esophagitis. Schweiz Med Wochenschr 198l;111:814-6.
88. Springer DJ, DaCosta LR, Beck IT. A syndrome of acute self-limiting ulcerative esophagitis in young adults probably due to herpes simplex virus. Dig Dis Sci 1979;24:535-9.
89. Giger M, Uehlinger M, Bansky G, et al. Herpes virus and Candida in oesophagitis: A prospective study. Scand J Gastroenterol 1982;17(suppl 78):61.
90. Jones DB, Mayberry JF, Rhodes J, et al. Preliminary report of an association between measles virus and achalasia. J Clin Pathol 1983;36:655-7.
91. Robertson CS, Martin BA, Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 1993;34:299-302.
92. Niwamoto H, Okamoto E, Fujimoto J, et al. Are human herpes viruses or measles virus associated with esophageal achalasia? Dig Dis Sci 1995;40:859-64.
93. Birgisson S, Galinski MS, Goldblum JR, et al. Achalasia is not associated with measles or known herpes and human papilloma viruses. Dig Dis Sci 1997;42:300-6.
94. Singaram C, Sweet MA, Belcaster GM, et al. A novel autoantibody exists in patients with esophageal achalasia. Gastroenterology 1994;106:A566 (Abstract).
95. Storch WB, Eckardt VF, Wienbeck M, et al. Autoantibodies to Auerbach's plexus in achalasia. Cell Mol Biol (Noisy-le-grand) 1995;41:1033-8.
96. Verne GN, Sallustio JE, Eaker EY. Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study. Dig Dis Sci 1997;42:307-13.
97. Moses PL, Ellis LM, Anees MR, et al. Serum from patients with achalasia contains antibodies directed against enteric, sympathetic, sensory and spinal neurons. Gastroenterology 2000;118:A1190 (Abstract).
98. Storch WB, Eckardt VF, Junginger T. Complement components and terminal complement complex in oesophageal smooth muscle of patients with achalasia. Cell Mol Biol (Noisy-le-grand) 2002;48:247-52.
99. Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci 2002;47:15-19.
100. Moses PL, Ellis LM, Anees MR, et al. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 2003;52:629-36.
101. Raymond L, Lach B, Shamji FM. Inflammatory aetiology of primary oesophageal achalasia: An immunohistochemical and ultrastructural study of Auerbach's plexus. Histopathology 1999;35:445-53.
102. Clark SB, Rice TW, Tubbs RR, et al. The nature of the myenteric infiltrate in achalasia: An immunohistochemical analysis. Am J Surg Pathol 2000;24:1153-8.
103. Hamilton RG, Harley JB, Bias WB, et al. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1988;31:496-505.
104. Fujisaku A, Frank MB, Neas B, et al. HLA-DQ gene complementation and other histocompatibility relationships in man with the anti-Ro/SSA autoantibody response of systemic lupus erythematosus. J Clin Invest 1990;86: 606-11.
105. Arnett FC, Hamilton RG, Reveille JD, et al. Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum 1989;32:413-19.
106. Harley JB, Reichlin M, Arnett FC, et al. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome. Science 1986;232:1145-7.
107. McHugh NJ, Whyte J, Artlett C, et al. Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: A serological and HLA study. Clin Exp Immunol 1994;96:267-74.
108. Wong RK, Maydonovitch CL, Metz SJ, et al. Significant DQwI association in achalasia. Dig Dis Sci 1989;34:349-52.
109. De la Concha EG, Fernandez-Arquero M, Mendoza JL, et al. Contribution of HLA class II genes to susceptibility in achalasia. Tissue Antigens 1998;52:381-4.
110. Verne GN, Hahn AB, Pineau BC, et al. Association of HLA-DR and -DQ alleles with idiopathic achalasia. Gastroenterology 1999;117:26-31.
111. Ruiz-de-León A, Mendoza J, Sevilla-Mantilla C, et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci 2002;47:15-19.